- Research works
- 74 ▲ 20% vs 2013–17
- Citations
- 2k 26.7 per fractional work
- Top-10% rate
- 22.5% record average 16.5%
- Open access
- 56% world 28%
Not ranked overall: Cidara Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 8.9×. Every wedge is a field page.
Which keywords describe research at Cidara Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Antifungal Therapy, Immunocompromised Patients, Candidiasis, Invasive Fungal Infections, Cancer Therapy, Drug Discovery and Pandemic.
- Anticancer Agents
- Vaginal Microbiome
- Targeted Therapy
- Industrial Applications
- Purinergic Signalling
- Nematodes
- Glycosylation
- Monoclonal Antibodies
- Click Chemistry
- Histoplasmosis
- Neuroprotection
- Biological Activities
- Antioxidant Activity
- Tumor Microenvironment
- Influenza
- Pathogenesis
- Inflammation
- Cancer Therapy
- Candidiasis
- Antifungal Therapy
- Epidemiology
- Immunocompromised Patients
- Invasive Fungal Infections
- Drug Discovery
- Pandemic
- Therapeutic Targets
- Virus
- Synthesis
- Diagnosis
- Fungal Pathogens
- Cryptococcal Disease
- Virulence Factors
- Copper-Catalyzed Cycloaddition
- Adenosine Receptors
- Medicinal Chemistry
- Pharmacology
- Drug Resistance
- Sexually Transmitted Infections
- Therapeutic Antibodies
- Enantioselective Reactions
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology20▲ 6.8×15 topics
- Antifungal Therapy14▲ 194×3 topics
- Immunocompromised Patients11▲ 224×2 topics
- Candidiasis10▲ 288×1 topic
- Invasive Fungal Infections10▲ 360×1 topic
- Cancer Therapy4▲ 9.0×7 topics
- Drug Discovery4▲ 14×5 topics
- Inflammation4▲ 2.4×10 topics
- Pandemic4▲ 11×3 topics
- Pathogenesis4▲ 8.3×3 topics
- Therapeutic Targets4▲ 20×3 topics
- Influenza3▲ 92×1 topic
- Virus3▲ 37×1 topic
- Tumor Microenvironment3▲ 12×4 topics
- Synthesis3▲ 6.7×5 topics
- Antioxidant Activity3▲ 6.6×3 topics
- Diagnosis3▲ 3.5×3 topics
- Biological Activities2▲ 17×4 topics
- Fungal Pathogens2▲ 19×2 topics
- Neuroprotection2▲ 8.7×2 topics
- Cryptococcal Disease2▲ 100×1 topic
- Histoplasmosis2▲ 100×1 topic
- Virulence Factors2▲ 17×2 topics
- Click Chemistry2▲ 37×1 topic
- Copper-Catalyzed Cycloaddition2▲ 90×1 topic
- Monoclonal Antibodies2▲ 21×3 topics
- Adenosine Receptors2▲ 103×1 topic
- Glycosylation2▲ 11×2 topics
- Medicinal Chemistry2▲ 6.9×2 topics
- Nematodes2▲ 42×2 topics
- Pharmacology2▲ 7.8×5 topics
- Purinergic Signalling2▲ 103×1 topic
- Drug Resistance2▲ 7.7×3 topics
- Industrial Applications2▲ 15×2 topics
- Sexually Transmitted Infections2▲ 44×1 topic
- Targeted Therapy2▲ 11×3 topics
- Therapeutic Antibodies2▲ 19×2 topics
- Vaginal Microbiome2▲ 81×1 topic
- Enantioselective Reactions2▲ 25×2 topics
- Anticancer Agents2▲ 8.7×4 topics
Which research topics does Cidara Therapeutics (United States) publish most on?
By volume in 2022–2025: Antifungal resistance and susceptibility, Adenosine and Purinergic Signaling, Click Chemistry and Applications and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Antifungal resistance and susceptibility Infectious Diseases 2 works
- 2 Adenosine and Purinergic Signaling Physiology 2 works
- 3 Click Chemistry and Applications Organic Chemistry 1 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 5 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
- 6 Nanoparticle-Based Drug Delivery Biomaterials 1 works
- 7 Influenza Virus Research Studies Epidemiology 1 works
- 8 Synthesis and Biological Evaluation Organic Chemistry 1 works
- 9 Immune Cell Function and Interaction Immunology 1 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Cidara Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 20% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Diego
- University of California San Diego
- San Diego State University
- Scripps Research Institute
- University of San Diego
- University of California San Diego Medical Center
- General Atomics (United States)
- Scripps Health
- Naval Medical Center San Diego
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.